Target Name: MIR147B
NCBI ID: G100126311
Review Report on MIR147B Target / Biomarker Content of Review Report on MIR147B Target / Biomarker
Other Name(s): MIRN147B | hsa-miR-147b-5p | mir-147b | hsa-mir-147b | MicroRNA 147b | microRNA 147b | hsa-miR-147b-3p

The Discovery of MIR147B: Unveiling a Promising Drug Target and Biomarker

In recent years, the field of biomedical research has witnessed remarkable progress in identifying novel drug targets and biomarkers for various diseases. Among the exciting discoveries is MIR147B, a microRNA molecule that has shown great potential for therapeutic interventions and diagnostics. This article will delve into the discovery and exploration of MIR147B, elucidating its significance as a drug target and biomarker.

The Fascinating World of MicroRNAs

Before we delve into the specifics of MIR147B, it is crucial to understand the broader context of microRNAs (miRNAs). MicroRNAs are a class of small non-coding RNA molecules that play significant roles in post-transcriptional gene regulation. They have emerged as essential regulators of gene expression, influencing various biological processes, including development, differentiation, and disease progression.

MIR147B: A Closer Look

MIR147B, also known as miR-147b-3p, is a specific microRNA molecule encoded by the MIR147B gene. It is found in humans and several other species. Like other miRNAs, MIR147B acts by binding to messenger RNA (mRNA) molecules, leading to the repression of gene expression. Consequently, MIR147B is implicated in modulating the expression of various target genes that control critical cellular pathways.

MIR147B as a Drug Target

The identification of miRNAs as potential drug targets has opened new avenues in pharmaceutical research. The dysregulation of MIR147B has been linked to several diseases, making it an attractive target for therapeutic interventions. Researchers have found that MIR147B expression is altered in several types of cancer, including breast, lung, and colorectal cancer. By designing molecules that selectively target MIR147B, it is possible to manipulate its expression levels, thereby modulating the entire network of genes controlled by this crucial miRNA.

Several studies have validated the therapeutic potential of targeting MIR147B in cancer treatment. For example, a research team successfully demonstrated that inhibiting MIR147B expression in breast cancer cells led to reduced cell proliferation and enhanced sensitivity to chemotherapeutic agents. These findings underscore the importance of MIR147B as a potential target for novel anticancer therapies.

Moreover, beyond cancer, MIR147B has also been implicated in other diseases, such as inflammatory bowel disease (IBD) and ischemic stroke. Its dysregulation in these conditions suggests that therapeutic interventions aimed at restoring the balance of MIR147B expression could hold promise for treating these devastating diseases.

MIR147B as a Biomarker

In addition to its potential as a drug target, MIR147B has garnered attention as a biomarker with diagnostic and prognostic value. Biomarkers are measurable substances that indicate the presence or severity of a disease, aiding in diagnosis, monitoring, and predicting treatment response.

Multiple studies have demonstrated the diagnostic or prognostic potential of MIR147B in various diseases. For instance, research conducted on patients with colorectal cancer revealed that the expression level of MIR147B in cancerous tissues was significantly lower compared to normal adjacent tissues. This finding suggests that quantifying MIR147B expression could serve as a non-invasive diagnostic tool for colorectal cancer.

Similarly, in ischemic stroke, MIR147B has shown promise as a prognostic biomarker. A study conducted on stroke patients indicated that higher MIR147B expression levels were associated with a favorable outcome and reduced mortality. These findings may enable clinicians to assess stroke severity and predict patient prognosis, facilitating personalized treatment plans.

The Future of MIR147B Research

The discovery of MIR147B has undoubtedly opened up exciting possibilities for therapeutic interventions and disease diagnosis. However, further research is needed to fully elucidate its role in different diseases and explore the potential of harnessing MIR147B as a therapeutic target or biomarker.

Future research should focus on understanding the mechanisms by which MIR147B regulates its target genes and the specific pathways involved. Moreover, preclinical and clinical studies investigating the efficacy and safety of modulating MIR147B expression are warranted. Such studies will pave the way for the development of novel therapies and diagnostic tools that can revolutionize the management of various diseases.

In conclusion, the discovery of MIR147B as a promising drug target and biomarker exemplifies the dynamic nature of biomedical research. Its implications in diseases ranging from cancer to stroke highlight its potential for improving patient outcomes and revolutionizing disease management approaches. As scientific understanding progresses, we can anticipate a future where MIR147B-based therapies and diagnostics become integral components of precision medicine.

Protein Name: MicroRNA 147b

The "MIR147B Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR147B comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at

More Common Targets

MIR148A | MIR148B | MIR149 | MIR150 | MIR151A | MIR151B | MIR152 | MIR153-1 | MIR153-2 | MIR1537 | MIR1538 | MIR1539 | MIR154 | MIR155 | MIR155HG | MIR1587 | MIR15A | MIR15B | MIR16-1 | MIR16-2 | MIR17 | MIR17HG | MIR181A1 | MIR181A1HG | MIR181A2 | MIR181A2HG | MIR181B1 | MIR181B2 | MIR181C | MIR181D | MIR182 | MIR1825 | MIR1827 | MIR183 | MIR184 | MIR185 | MIR186 | MIR187 | MIR188 | MIR18A | MIR18B | MIR1908 | MIR1909 | MIR190A | MIR190B | MIR191 | MIR1910 | MIR1911 | MIR1912 | MIR1913 | MIR1914 | MIR1915 | MIR1915HG | MIR192 | MIR193A | MIR193B | MIR193BHG | MIR194-1 | MIR194-2 | MIR194-2HG | MIR195 | MIR196A1 | MIR196A2 | MIR196B | MIR197 | MIR1972-1 | MIR1972-2 | MIR1973 | MIR1976 | MIR198 | MIR199A1 | MIR199A2 | MIR199B | MIR19A | MIR19B1 | MIR19B2 | MIR200A | MIR200B | MIR200C | MIR200CHG | MIR202 | MIR202HG | MIR203A | MIR203B | MIR204 | MIR205 | MIR2052 | MIR2052HG | MIR2053 | MIR2054 | MIR205HG | MIR206 | MIR208A | MIR208B | MIR20A | MIR20B | MIR21 | MIR210 | MIR210HG | MIR211